Callan Family Office’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.04M Sell
13,776
-497
-3% -$137K 0.06% 288
2026
Q1
$4.22M Sell
14,273
-399
-3% -$119K 0.1% 218
2025
Q4
$4.01M Buy
14,672
+1,551
+12% +$421K 0.09% 219
2025
Q3
$3.55M Sell
13,121
-518
-4% -$141K 0.11% 189
2025
Q2
$3.76M Buy
13,639
+11,075
+432% +$3.01M 0.12% 187
2025
Q1
$680K Sell
2,564
-7,320
-74% -$1.81M 0.05% 270
2024
Q4
$2.3M Buy
+9,884
New +$2.27M 0.15% 132

Other funds holding CME

Callan Family Office's CME Position: Q2 2026 in Review

Callan Family Office reduced its CME Group (CME) stake by 3.5% in Q2 2026, selling an estimated $137K and leaving 13,776 shares worth $3.04M. The position accounts for 0.06% of the portfolio, ranked #288.

Callan Family Office first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.22M in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Callan Family Office held 13,776 shares of CME Group worth $3.04M as of Q2 2026.
  • Callan Family Office sold 497 CME Group shares in Q2 2026, an estimated $137K.
  • CME Group made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #288 holding.
  • Callan Family Office first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's CME Group position peaked at $4.22M in Q1 2026.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.